1,001 results on '"C, Compton"'
Search Results
2. Assessment of a virtual reality temporal bone surgical simulator: a national face and content validity study
3. Overview of Fragment Separator Superconducting Magnets in the Facility for Rare Isotope Beams
4. Correction to: Assessment of a virtual reality temporal bone surgical simulator: a national face and content validity study
5. Inadvertently Generated PCBs in Consumer Products: Concentrations, Fate and Transport, and Preliminary Exposure Assessment
6. The Airway Microbiome in Chronic Bronchitis Is Intermediate Between Health and Chronic Obstructive Pulmonary Disease
7. Quantitative CT Parameters in Chronic Bronchitis Without Airflow Limitation, COPD and Healthy Controls
8. Data from Association of TP53 Mutational Status and Gender with Survival after Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803
9. Supplementary Figures from Association of TP53 Mutational Status and Gender with Survival after Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803
10. Supplementary Information from Association of TP53 Mutational Status and Gender with Survival after Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803
11. Comparative effectiveness of umeclidinium/vilanterol versus indacaterol/glycopyrronium on acute exacerbations in patients with chronic obstructive pulmonary disease in England
12. Netzwerk-Metaanalyse (NMA) der Wirksamkeit von Fluticasonfuroat/Umeclidinium/Vilanterol (FF/UMEC/VI) im Vergleich zu anderen Tripel-Therapien zur Behandlung der chronisch obstruktiven Lungenerkrankung (COPD): ein Vergleich der annualisierten Raten an moderaten und schweren Exazerbationen
13. S79 COPD exacerbations in routine clinical practice during COVID-19 in England in 2020
14. S39 COVID-19 incidence and hospitalisation in routine clinical practice among asthma patients in England in 2020
15. S75 Asthma exacerbations in routine clinical practice during COVID-19 in England in 2020
16. Reduced exacerbations following switch from multiple-inhaler to once-daily single-inhaler triple therapy in COPD patients in a real-world primary care setting in England
17. Rescue medication use in patients with chronic obstructive pulmonary disease receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol in England
18. COVID-19 incidence and hospitalization in routine clinical practice among COPD patients in England in 2020
19. Benefit of prompt initiation of single-inhaler triple therapy in COPD patients in England following an exacerbation
20. Adherence to umeclidinium/vilanterol versus inhaled corticosteroids/long-acting β2-agonist in patients with chronic obstructive pulmonary disease in England
21. Identifying risk of first COPD exacerbation in COPD patients in GOLD group A/B in the UK
22. Health status, activity score and dyspnoea grade in chronic bronchitis, COPD and healthy controls in China
23. TNM-Supplement: Erlauterungen zur einheitlichen Anwendung
24. Comparaison de l’efficacité de l’uméclidinium/vilantérol (l’UMEC/VI) par rapport à d’autres bronchodilatateurs pour le traitement de la BPCO : revue systématique de la littérature et méta-analyse en réseau
25. EPH151 Clinical and Economic Benefits of Prompt Initiation of Single-Inhaler Triple Therapy in COPD Patients in England Following an Exacerbation
26. Developing an Artificial Intelligence Tool to Predict Vocal Cord Pathology in Primary Care Settings
27. Impact of the COVID-19 Pandemic on Health Care Resource Utilization (HCRU) and Costs in Asthma in the United States: A Population-Based Study
28. Network Meta-Analysis of the Efficacy of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Versus Other Triple Therapies for the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comparison of Annual Moderate and Severe Exacerbations
29. Comparative Efficacy of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Versus Other Triple Therapies for the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review and Network Meta-Analysis
30. Impact of the COVID-19 Pandemic on Health Care Resource Utilization (HCRU) and Costs in Chronic Obstructive Pulmonary Disease (COPD) in the United States: A Population-Based Study
31. Comparative Efficacy of UMEC/VI Versus Other Bronchodilators for the Treatment of COPD: A Systematic Literature Review and Network Meta-Analysis
32. Impact of the COVID-19 Pandemic on Asthma Exacerbations in the United States: A Population-Based Study
33. Trends in COVID-19 Incidence Among Patients with Asthma in 2020: A Population-Based Study in the United States
34. Impact of the COVID-19 Pandemic on Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in the United States: A Population-Based Study
35. Impact of the COVID-19 Pandemic on Dispensing of Respiratory Therapies Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in the United States: A Population-Based Study
36. Trends in COVID-19 Incidence Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in 2020: A Population-Based Study in the United States
37. Accelerator commissioning and rare isotope identification at the Facility for Rare Isotope Beams
38. Insights into the Relationships Among the Roof, Rib, Floor, and Pillars of Underground Coal Mines
39. Assessment of a virtual reality temporal bone surgical simulator: a national face and content validity study
40. Maslow and the Good Person
41. Méta-analyse en réseau sur l’efficacité du fuorate de fluticasone/uméclidinium/vilantérol (FF/UMEC/VI) par rapport aux autres trithérapies dans le traitement de la bronchopneumopathie chronique obstructive (BPCO) : une comparaison des taux annualisés des exacerbations modérées et sévères
42. Les bénéfices d’une initiation rapide de la triple thérapie en inhalateur unique après une exacerbation chez des patients avec bronchopneumopathie chronique obstructive (BPCO) en Angleterre
43. EPH198 Assessing the Validity of Netherlands Linked Routine Healthcare Resource Utilisation Data in the Investigation of Single-Inhaler Triple Therapy Effectiveness (INTREPID Trial)
44. SA7 Reduced Health Care Resource Utilisation and Costs Following a Switch From Multiple-Inhaler to Once-Daily Single-Inhaler Triple Therapy in COPD Patients in a Real-World Primary Care Setting in England
45. SA62 Impact of the COVID-19 Pandemic on Health Care Resource Utilisation and Costs in Asthma in England: A Population-Based Study
46. Introduction
47. Discussion
48. Results
49. African American Children who have Experienced Homelessness
50. Literature Review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.